Last reviewed · How we verify
phosphorylcholine
phosphorylcholine is a drug. It is currently in unknown development.
Phosphorylcholine is a hydrophilic polar head group of some phospholipids, composed of a negatively charged phosphate bonded to a small, positively charged choline group. It is a small molecule modality that has been studied in various clinical trials for conditions such as corneal ulcers, coronary disease, and coronary artery disease.
At a glance
| Generic name | phosphorylcholine |
|---|---|
| Therapeutic area | Other |
| Phase | unknown |
Approved indications
Common side effects
Key clinical trials
- Phase 1, Open-Label, Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple Myeloma (Phase 1)
- A Randomized, Double-Blind, 12-Week, Dose-Ranging Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral VB-201 in Patients With Moderate to Severe Plaque Psoriasis (Phase 2)
- Randomized, Active-controlled, Double-blind, Parallel Design Study to Evaluate the Efficacy and Safety of a Once-a-week Prophylaxis Treatment With BAY79-4980 Compared to Three Times-per-week Prophylax (Phase 2)
- A Randomized, Double Blind, Dose Ranging, Placebo Controlled Study to Evaluate the Efficacy and Safety of Oral VB-201 in Patients With Moderate to Severe Plaque Psoriasis (Phase 2)
- Phase 1, Open-Label, Randomized Study of the Safety and Immunogenicity of a SARS-CoV-2 Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults (Phase 1)
- A Randomized, Blinded, Two-part, Phase II Trial to Evaluate the Safety and Immunogenicity of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults 18 Years and Older (Phase 2)
- A Phase II, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Effect of Multiple Doses of VB-201 on Biomarkers (Phase 2)
- A Randomized, Observer-Blinded, Placebo-Controlled Phase I Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of One Dose Booster by A Lyophilized COVID-19 mRNA Vaccine in Adults Aged 18 (Phase 1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- phosphorylcholine CI brief — competitive landscape report
- phosphorylcholine updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about phosphorylcholine
What is phosphorylcholine?
What development phase is phosphorylcholine in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing